Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TNYA)

CUSIP: 87990A106

Q1 2025 13F Holders as of 31 Mar 2025

Holder snapshot 7 signals
Share change
+4,569,275
Put/Call ratio
105%
SEC-reported price per share
$0.57
Number of holders
104
Value change
+$1,982,469
Number of buys
49
Open additional details 1 more signal available
Number of sells
39
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
222,722,404

Security key

87990A106

Report period

Q1 2025

Institutions

104

Top holders

10

Ownership snapshot

Top reported holders of TNYA - Tenaya Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Casdin Capital, LLC
Disclosed value leader
Eli Casdin
Comparable rows
2/15
Latest evidence
31 Dec 2024
13F 13D/G 3/4/5 Lead comparable stake: 4.3% 13 rows are not safely comparable across share classes. 13D/G row: Casdin Capital, LLC Showing 1-6 of 15 holder rows.

Quick read

Casdin Capital, LLC leads the comparable SEC ownership view at 4.3%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Casdin Capital, LLC's linked filing trail.
Comparable ownership Top 2
Casdin Capital, LLC 4.3%
JPMORGAN CHASE & CO 2.8%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Casdin Capital, LLC
13F 13D/G
Company
4.3%
Reported 13D/G · 04 Mar 2025
$9,628,149
6,732,971 shares
— 31 Dec 2024
JPMORGAN CHASE & CO
13F 13D/G
Company
2.8%
Reported 13D/G · 28 Feb 2025
$7,372,502
5,155,596 shares
— 31 Dec 2024
Casdin Partners Master Fund, L.P.
3/4/5
10%+ Owner
—
denominator unverified
$1,541,988
361,969 shares
— 03 Aug 2021
Eli Casdin
3/4/5
Director
—
mixed-class rows
$25,895,944
7,472,698 shares
mixed-class rows
— 17 Nov 2022
Column Group LLC
13F
Company
13F
—
denominator unverified
$13,442,415
9,400,290 shares
— 31 Dec 2024
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$7,573,961
5,296,476 shares
— 31 Dec 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
104
Shares
48,166,604
Rows available
104
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2025 vs Q1 2025 Across Filers

Q1 2025 holders
104
Q1 2025 holders
104
Holder diff
0
Investor Q1 2025 Shares Q1 2025 Shares Share Diff Share Chg % Q1 2025 value Q1 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .